Sennoside A, a kind of irritant laxative isolated from rhei rhizome, causes purgative actions in the intestine.

Sodium diethyldithiocarbamate can accelerate the rate of copper cementation and reduce HIV infection.

Nelfinavir is a selective and potent HIV-1 protease inhibitor used in combination with other antiviral drugs in the treatment of HIV.

AMD 3465 hexahydrobromide is a potent, selective CXCR4 antagonist and exhibits 8-fold higher affinity than AMD 3100 and inhibits SDF-1α-ligand binding (Ki = 41.7 nM).

BMS-707035 is a potent, specific, reversible HIV-I integrase inhibitor with IC50 value of 15 nM.

Trovirdine inhibits HIV-1 RT with an IC50 of 7 nM when employing heteropolymeric primer/template (oligo-DNA/ribosomal RNA)and dGTP as substrate.

YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.

Dolutegravir sodium is an HIV integrase inhibitor (IC50= 2.7 nM) with modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

Trilobatin, a natural product isolated and purified from the herbs of Lithocarpus pachyphyllus with anti-oxidant effect, potentially inhibits the LPS-induced inflammatory response by suppressing the NF-κB signaling pathway and is a potential effective α-glucosidase inhibitor for management of postprandial hyperglycemia with less side effect.

BMS-378806 selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.

PF-3450074 blocks HIV-1 at an early postentry stage by binding the viral capsid and interfering with its function.

MK-8591 exhibits potent activity against HIV.

Atazanavir Sulfate is a protease inhibitor used as an antiretroviral medication to treat and prevent HIV/AIDS.

Delavirdine mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).